The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum
Abstract
Acetylcholine release stimulated by nicotinic agonists was measured as radioactivity released from perfused synaptosomes prepared from mouse interpeduncular nucleus (IPN) that had been loaded with [(3)H]choline. Agonist-stimulated release was dependent upon external calcium and over 90% of released radioactivity was acetylcholine. The release process was characterized by dose response curves for 13 agonists and inhibition curves for six antagonists. alpha-Conotoxin MII did not inhibit this release, while alpha-conotoxin AuIB inhibited 50% of agonist-stimulated release. Comparison of this process with [(3)H]dopamine release from mouse striatal synaptosomes indicated that different forms of nicotinic acetylcholine receptors (nAChRs) may mediate these processes. This was confirmed by assays using mice homozygous for the beta 2 subunit null mutation. The deletion of the beta 2 subunit had no effect on agonist-stimulated acetylcholine release, but abolished agonist-stimulated release of dopamine from striatal synaptosomes. Mice heterozygous for the beta 2 subunit null mutation showed decreased dopamine release evoked by L-nicotine with no apparent change in EC(50) value, as well as similar decreases in both transient and persistent phases of release with no changes in desensitization rates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Knockout of the β2 subunit abolishes nicotine-mediated DA release (Picciotto et al. 1998;Grady et al. 2001), nicotine-induced locomotor activation (King et al. 2004), nicotine selfadministration (Picciotto et al. 1998;Maskos et al. 2005), and nicotine place preference (Walters et al. 2006;Brunzell et al. 2009;Mineur et al. 2009a).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Grady et al. 2001
In the citing paper
“Nicotinic modulation of neurotransmitter release is often subtype-specific and this specificity can vary across brain areas, with distinct nAChRs coupling to release of glutamate (α7) vs. GABA (α4β2*) (Mansvelder et al., 2002) or DA (α4/α6β2*) vs. ACh (α3β4*) (Grady et al., 2001) in the VTA, while β2* nAChRs can modulate the release of glutamate from thalamo-cortical projections (Parikh et al., 20”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as Grady et al., 2001
Citations
Cites
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationThe Diversity of Neuronal Nicotinic Acetylcholine Receptors
Sargent, P. B. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.002155 · Cited by 1,052
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668
Self-citationPRESYNAPTIC IONOTROPIC RECEPTORS AND THE CONTROL OF TRANSMITTER RELEASE
MacDermott, A. B., Role, L. W., & Siegelbaum, S. A. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.443 · Cited by 570
Luetje, C., & Patrick, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-03-00837.1991 · Cited by 558
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 538
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Synapse · doi:10.1002/syn.890160105 · Cited by 521
A New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine Receptors
Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. M., & McIntosh, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7522 · Cited by 489
Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 404
Research works printed but not linked: 1
- Chavez‐Noriega L. E., 1997, Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes, J. Pharmacol. Exp. Ther., 280, 346
Cited by
Sorted by citations
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 512
Effect of nicotine and nicotinic receptors on anxiety and depression
Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483
Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282
Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2199-07.2007 · Cited by 274
Self-citationPicciotto, M. R., & Corrigall, W. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03338.2002 · Cited by 265
Azam, L., Winzer‐Serhan, U. H., Chen, Y.-L., & Leslie, F. M. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10138 · Cited by 261
Nicotine as a modulator of behavior: beyond the inverted U
Picciotto, M. R. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00230-x · Cited by 257
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252
Self-citationPerry, D. C., Xiao, Y., Nguyen, H. N., Musachio, J. L., Dávila‐García, M. I., & Kellar, K. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00951.x · Cited by 255
Grady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., Clementi, F., & Gotti, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5121-08.2009 · Cited by 222
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221
Self-citationNicotinic Agonists, Antagonists, and Modulators From Natural Sources
Daly, J. W. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-3968-4 · Cited by 195
Neuronal nicotinic receptors: from protein structure to function
Itier, V., & Bertrand, D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02702-8 · Cited by 190
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors
Azam, L., & McIntosh, J. M. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.47 · Cited by 179
Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint
Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 186
Pimlott, S. L., Piggott, M. A., Owens, J., Greally, E., COURT, J. A., Jaros, E., Perry, R. H., Perry, E. K., & Wyper, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300302 · Cited by 170
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study
Picard, F., Bruel, D., Servent, D., Saba, W., Fruchart‐Gaillard, C., Peyronneau, M., Roumenov, D., Brodtkorb, E., Zuberi, S. M., Gambardella, A., et al. (2006) · Brain · doi:10.1093/brain/awl156 · Cited by 170
Jones, I. W., Bolam, J. P., & Wonnacott, S. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1345 · Cited by 168
McGranahan, T. M., Patzlaff, N. E., Grady, S. R., Heinemann, S. F., & Booker, T. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0937-11.2011 · Cited by 165
Self-citationCosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 165
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Nicotine self‐medication of cognitive‐attentional processing
Evans, D. E., & Drobes, D. J. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00130.x · Cited by 152
Salminen, O., Drapeau, J. A., McIntosh, J. M., Collins, A. C., Marks, M. J., & Grady, S. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031492 · Cited by 151
Involvement of the α3 Subunit in Central Nicotinic Binding Populations
Whiteaker, P., Peterson, C. G., Xu, W., McIntosh, J. M., Paylor, R. E., Beaudet, A. L., Collins, A. C., & Marks, M. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02522.2002 · Cited by 145
Mogg, A. J., Whiteaker, P., McIntosh, J. M., Marks, M. J., Collins, A. C., & Wonnacott, S. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.197 · Cited by 146
Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction
Mineur, Y. S., & Picciotto, M. R. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.010 · Cited by 139
Tuesta, L. M., Fowler, C. D., & Kenny, P. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.026 · Cited by 135
Nicotine and Nicotinic Receptors; Relevance to Parkinson’s Disease
Quik, M., & Kulak, J. M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00036-0 · Cited by 129
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine Release
Zhang, L., Zhou, F.-M., & Dani, J. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000299 · Cited by 122
Molecules and circuits involved in nicotine addiction: The many faces of smoking
Picciotto, M. R., & Mineur, Y. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.028 · Cited by 123
Grady, S. R., Murphy, K. L., Cao, J., Marks, M. J., McIntosh, J. M., & Collins, A. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.651 · Cited by 110
Self-citationNicke, A., Wonnacott, S., & Lewis, R. J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04145.x · Cited by 109
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 112
Chiamulera, C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.08.005 · Cited by 110
Grady, S. R., Drenan, R. M., Breining, S. R., Yohannes, D., Wageman, C. R., Fedorov, N. B., McKinney, S., Whiteaker, P., Bencherif, M., Lester, H. A., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.013 · Cited by 98
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112
Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95
Shoaib, M., Gommans, J., Morley, A., Stolerman, I. P., Grailhe, R., & Changeux, J.-P. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00194-0 · Cited by 110
Smith, J. W., Mogg, A. J., Tafi, E., Peacey, E., Pullar, I. A., Szekeres, P. G., & Tricklebank, M. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0596-8 · Cited by 94
The Genetic Components of Alcohol and Nicotine Co-Addiction: From Genes to Behavior
Schlaepfer, I. R., Hoft, N. R., & Ehringer, M. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801020124 · Cited by 96
Champtiaux, N., & Changeux, J. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339247 · Cited by 88
Quik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 86
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms
Dutertre, S., Nicke, A., & Tsetlin, V. I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.011 · Cited by 77
Glick, S. D., Ramirez, R. L., Livi, J. M., & Maisonneuve, I. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.045 · Cited by 76
Kulak, J. M., McIntosh, J. M., Yoshikami, D., & Olivera, B. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00357.x · Cited by 73
Brunzell, D. H., Chang, J. R., Schneider, B., Olausson, P., Taylor, J. R., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0099-z · Cited by 71
Self-citationKing, S. L., Caldarone, B. J., & Picciotto, M. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.024 · Cited by 70
Jackson, K. J., Sanjakdar, S. S., Muldoon, P. P., McIntosh, J. M., & Damaj, M. I. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.017 · Cited by 69
Self-citationNeuronal nicotinic receptors: insights gained from gene knockout an knocking mutant mice
Drago, J., McColl, C. D., Horne, M. K., Finkelstein, D. I., & Ross, S. A. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2259-9 · Cited by 69
van Nierop, P., Bertrand, S., Munno, D. W., Gouwenberg, Y., van Minnen, J., Spafford, J. D., Syed, N. I., Bertrand, D., & Smit, A. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508571200 · Cited by 66
Salminen, O., Whiteaker, P., Grady, S. R., Collins, A. C., McIntosh, J. M., & Marks, M. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.011 · Cited by 63
Down-regulation of cholinergic signaling in the habenula induces anhedonia-like behavior
Han, S., Yang, S. H., Kim, J. Y., Mo, S., Yang, E., Song, K. M., Ham, B., Mechawar, N., Turecki, G., Lee, H. W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01088-6 · Cited by 67
Grady, S. R., Salminen, O., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9263-y · Cited by 61
Spiller, K., Xi, Z.-X., Li, X., Ashby, C. R., Callahan, P. M., Tehim, A., & Gardner, E. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.006 · Cited by 58
Azam, L., & McIntosh, J. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024513 · Cited by 56
Pickard, J. M. J., Burke, N., Davidson, S. M., & Yellon, D. M. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0601-x · Cited by 56
Nicotinic receptor-based therapeutics and candidates for smoking cessation
Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.002 · Cited by 57
Kulak, J. M., McIntosh, J. M., & Quik, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.230 · Cited by 56
Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 57
Neuronal Nicotinic Acetylcholine Receptor Modulators from Cone Snails
Abraham, N., & Lewis, R. J. (2018) · Marine Drugs · doi:10.3390/md16060208 · Cited by 53
Champtiaux, N., & Changeux, J. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45016-4 · Cited by 56
Kulak, J. M., Sum, J., Musachio, J. L., McIntosh, J. M., & Quik, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00868.x · Cited by 53
McCallum, S. E., Parameswaran, N., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012773 · Cited by 52
Multiple brain pathways and receptors underlying tobacco addiction
Rose, J. E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.039 · Cited by 51
Drenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 55
Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice
Booker, T. K., Butt, C. M., Wehner, J. M., Heinemann, S. F., & Collins, A. C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.011 · Cited by 49
Grinevich, V. P., Letchworth, S. R., Lindenberger, K. A., Ménager, J., Mary, V., Sadieva, K. A., Buhlman, L. M., Böhme, G. A., Pradier, L., Bénavidès, J., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075069 · Cited by 44
Neuronal networks of nicotine addiction
Ortells, M. O., & Arias, H. R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.019 · Cited by 44
Kulak, J. M., Musachio, J. L., McIntosh, J. M., & Quik, M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039347 · Cited by 43
Luetje, C. W. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1333 · Cited by 43
Effect of neuroactive compounds on the settlement of mussel (Perna canaliculus) larvae
Young, T., Alfaro, A. C., & Robertson, J. (2011) · Aquaculture · doi:10.1016/j.aquaculture.2011.06.050 · Cited by 42
Grilli, M., Patti, L., Robino, F., Zappettini, S., Raiteri, M., & Marchi, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05307.x · Cited by 40
McColl, C. D. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00369-6 · Cited by 38
Azam, L., & McIntosh, J. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071456 · Cited by 37
In vivo modulation of α7 nicotinic receptors on striatal glutamate release induced by anatoxin-A
Campos, F., Alfonso, M., & Durán, R. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.010 · Cited by 38
Grasing, K. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.022 · Cited by 39
Sala, M., Braida, D., Pucci, L., Manfredi, I., Marks, M. J., Wageman, C. R., Grady, S. R., Loi, B., Fucile, S., Fasoli, F., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02204.x · Cited by 36
Mogg, A. J., Jones, F. A., Pullar, I. A., Sharples, C. G. V., & Wonnacott, S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.013 · Cited by 34
Mineur, Y. S., Brunzell, D. H., Grady, S. R., Lindstrom, J. M., McIntosh, J. M., Marks, M. J., King, S. L., & Picciotto, M. R. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00468.x · Cited by 33
Nasehi, M. M., Mafi, F., Oryan, S., Nasri, S., & Zarrindast, M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.011 · Cited by 37
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 33
Section I. The Cholinergic System
Smythies, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)64001-9 · Cited by 32
Marks, M. J., Whiteaker, P., Grady, S. R., Picciotto, M. R., McIntosh, J. M., & Collins, A. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00910.x · Cited by 32
Selectivity of ABT-089 for α4β2* and α6β2* nicotinic acetylcholine receptors in brain
Marks, M. J., Wageman, C. R., Grady, S. R., Gopalakrishnan, M., & Briggs, C. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.022 · Cited by 30
Hone, A. J., Talley, T. T., Bobango, J., Melo, C. H., Hararah, F., Gajewiak, J., Christensen, S. B., Harvey, P. J., Craik, D. J., & McIntosh, J. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005649 · Cited by 29
Arias, H. R., Feuerbach, D., Targowska‐Duda, K. M., Kaczor, A. A., Poso, A., & Jóźwiak, K. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.11.003 · Cited by 25
Biała, G., & Staniak, N. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.04.022 · Cited by 23
Tobacco addiction: A biochemical model of nicotine dependence
Ortells, M. O., & Barrantes, G. E. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.11.004 · Cited by 26
Presynaptic lonotropic Receptors
Dorostkar, M. M., & Boehm, S. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_15 · Cited by 25
L-DOPA Treatment Modulates Nicotinic Receptors in Monkey Striatum
Quik, M., Bordia, T., Okihara, M., Fan, H., Marks, M. J., McIntosh, J. M., & Whiteaker, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.619 · Cited by 27
Butt, C. M., Hutton, S. R., Marks, M. J., & Collins, A. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01135.x · Cited by 23
Beiranvand, F., Zlabinger, C., Orr‐Urtreger, A., Ristl, R., Huck, S., & Scholze, P. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12841 · Cited by 22
Molecular Mechanisms Underlying the Motivational Effects of Nicotine
Brunzell, D. H., & Picciotto, M. R. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_3 · Cited by 22
Varaschin, R. K., Osterstock, G., Ducrot, C., Leino, S., Bourque, M.-J., Prado, M. A. M., Prado, V. F., Salminen, O., Nuutinen), S. R. (., & Trudeau, L. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.027 · Cited by 24
Sorger, D., Becker, G., Patt, M., Schildan, A., Großmann, U., Schliebs, R., Seese, A., Kendziorra, K., Kluge, M., Brust, P., et al. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.12.008 · Cited by 22
Metadata
- Authors
- Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C.
- Affiliations
- University of Colorado Boulder (US)
- Yale University (US)
- Centre National de la Recherche Scientifique (FR)
- University of Utah (US)
- Corresponding author
- Collins, Allan C.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 76
- Issue
- 1
- Pages
- 258-268
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1515685619
- Cited by
- 156
- References
- 48
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 11 · 2013: 3 · 2012: 7
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH53631)
- National Institute on Drug Abuse (DA 03194, R01DA003194, R01DA012242, DA12242)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, acetylcholine release, interpeduncular nucleus, dopamine release, striatum, alpha-conotoxin MII, nicotinic agonists, calcium-dependent release, receptor desensitization, synaptosomes
- MeSH terms
- Quinolizidine Alkaloids, Acetylcholine, Alkaloids, Animals, Azocines, Calcium, Choline, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Female, Heterozygote, Homozygote, Male, Mesencephalon, Mice, Inbred C57BL, Mice, Mutant Strains, Quinolizines, Receptors, Nicotinic, Synaptosomes, Presynaptic Terminals, Nicotinic Agonists, Nicotinic Antagonists, Conotoxins, Protein Subunits, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review